This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

AVANIR Pharmaceuticals (AVNR)

NASDAQ: Health Care

Company Balance Sheet
Sep 2014 Sep 2013 Sep 2012 Sep 2011
Assets
Cash and Equivalents 271.87M 55.26M 69.78M 79.54M
Receivables 22.83M 12.53M 7.23M 2.01M
Inventories 799.00K 710.18K 415.48K 252.24K
Other Current Assets 4.00M 2.38M 865.34K 520.49K
Total Current Assets 300.82M 71.84M 80.91M 84.39M
Property, Plant & Equipment, Gross 8.38M 4.99M 4.38M 3.57M
Accumulated Depreciation & Depletion 4.75M 3.40M 2.58M 1.88M
Property, Plant & Equipment, Net 3.63M 1.59M 1.81M 1.70M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 2.54M 2.64M 3.29M 3.56M
Total Non-Current Assets 6.17M 4.24M 5.10M 5.26M
Liabilities & Shareholder Equity
Total Assets 306.98M 76.08M 86.01M 89.65M
Accounts Payable 6.72M 5.88M 2.93M 3.26M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 344.86K 0.00 0.00
Total Current Liabilities 32.09M 34.79M 20.32M 14.19M
Long Term Debt 0.00 21.42M 26.70M 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 1.50M 1.39M 2.16M 4.12M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 1.50M 22.82M 28.86M 4.12M
Total Liabilities 33.59M 57.61M 49.17M 18.31M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 273.39M 18.47M 36.84M 71.34M
Common Par 19.00K 15.21K 13.64K 12.54K
Additional Paid In Capital 824.34M 518.99M 461.88M 436.64M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -550.97M -500.54M -425.06M -365.32M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization 273.39M 39.89M 63.54M 71.34M
Total Equity 273.39M 18.47M 36.84M 71.34M
Total Liabilities & Stock Equity 306.98M 76.08M 86.01M 89.65M
Total Common Shares Outstanding 193.67M 152.06M 136.44M 125.44M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 161.27M 142.27M 133.36M 119.41M
Diluted Weighted Shares Outstanding 161.27M 142.27M 133.36M 119.41M
Number of Employees 484 267 225 188
Number of Part-Time Employees 0 0 0 0
AVNR News

AVNR AVANIR Pharmaceuticals

Analysts Ratings for AVNR

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 5 3 3
Moderate Buy 0 0 0 0
Hold 3 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET AVNR ANALYST REPORT

Brokerage Partners

AVNR Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs